Protective Role of Optineurin Against Joint Destruction in Rheumatoid Arthritis Synovial Fibroblasts

Arthritis Rheumatol. 2020 Sep;72(9):1493-1504. doi: 10.1002/art.41290. Epub 2020 Aug 3.

Abstract

Objective: Optineurin (OPTN) is an autophagy adaptor/receptor that acts as an intrinsic negative regulator of osteoclast differentiation. RANKL expressed by rheumatoid arthritis synovial fibroblasts (RASFs) is primarily responsible for the development of bone erosions in patients with RA. The aim of the present study was to explore the role of OPTN in the pathogenesis of joint destruction in RA.

Methods: RASFs were left untreated or incubated with tumor necrosis factor (TNF) or interferon-γ (IFNγ), and expression of OPTN by RASFs was analyzed by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and Western blotting. Expression of RANKL and osteoprotegerin (OPG) was evaluated in cultures of OPTN-reduced RASFs with or without TNF or IFNγ treatment. OPTN-reduced RASFs were cocultured with monocytes and stained for tartrate-resistant acid phosphatase (TRAP). IκBα, NF-κB1, and RelA protein levels were measured to evaluate NF-κB signaling. Expression of messenger RNA (mRNA) for matrix metalloproteinase 3 (MMP3), interleukin-6 (IL6), GATA binding protein 3 (GATA3), carbohydrate sulfotransferase 15 (CHST15), hyaluronan synthase 1 (HAS1), and GATA1 was analyzed by RT-qPCR.

Results: In RASFs incubated with TNF or IFNγ, OPTN expression was up-regulated and RANKL expression was increased, and these effects were further pronounced in OPTN-reduced RASFs (all P < 0.05 versus controls). OPG mRNA levels remained unchanged. Monocytes cocultured with OPTN-reduced RASFs differentiated to a greater extent into TRAP+ multinucleated cells compared to monocytes cocultured with control RASFs (P < 0.05). IκBα degradation and nuclear NF-κB1 expression following TNF treatment were both prolonged in OPTN-reduced RASFs (each P < 0.05 versus controls). MMP3 mRNA levels were up-regulated, while GATA3, CHST15, and HAS1 mRNA levels were down-regulated in OPTN-reduced RASFs (each P < 0.05 versus controls).

Conclusion: OPTN plays a protective role in RA when it is up-regulated in RASFs in the presence of proinflammatory cytokines. Absence of OPTN might worsen RA by generating a joint-destructive state, as indicated by evidence of increased RANKL expression on RASFs and subsequent osteoclast differentiation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arthritis, Rheumatoid / genetics*
  • Arthritis, Rheumatoid / metabolism
  • Blotting, Western
  • Cell Cycle Proteins / genetics*
  • Cell Cycle Proteins / metabolism
  • Cell Differentiation
  • Coculture Techniques
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism*
  • GATA1 Transcription Factor / genetics
  • GATA3 Transcription Factor / genetics
  • Humans
  • Hyaluronan Synthases / genetics
  • Interferon-gamma / pharmacology
  • Interleukin-6 / genetics
  • Matrix Metalloproteinase 3 / genetics
  • Membrane Glycoproteins / genetics
  • Membrane Transport Proteins / genetics*
  • Membrane Transport Proteins / metabolism
  • Monocytes
  • NF-KappaB Inhibitor alpha / metabolism
  • NF-kappa B p50 Subunit / metabolism
  • Osteoprotegerin / metabolism
  • RANK Ligand / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sulfotransferases / genetics
  • Synovial Membrane / cytology*
  • Tartrate-Resistant Acid Phosphatase / metabolism
  • Transcription Factor RelA / metabolism
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • CHST15 protein, human
  • Cell Cycle Proteins
  • GATA1 Transcription Factor
  • GATA1 protein, human
  • GATA3 Transcription Factor
  • GATA3 protein, human
  • IL6 protein, human
  • Interleukin-6
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • NF-kappa B p50 Subunit
  • NFKB1 protein, human
  • OPTN protein, human
  • Osteoprotegerin
  • RANK Ligand
  • RELA protein, human
  • TNFRSF11B protein, human
  • TNFSF11 protein, human
  • Transcription Factor RelA
  • Tumor Necrosis Factor-alpha
  • NF-KappaB Inhibitor alpha
  • Interferon-gamma
  • HAS1 protein, human
  • Hyaluronan Synthases
  • Sulfotransferases
  • Tartrate-Resistant Acid Phosphatase
  • MMP3 protein, human
  • Matrix Metalloproteinase 3